# Intellia Therapeutics, Inc.: Form 8-K, filed Apr 15, 2024

- Company: [Intellia Therapeutics, Inc.](/companies/ntla.md) (CIK 1652130)
- Form: 8-K
- Filed: 2024-04-15
- Accepted by EDGAR: Apr 15, 2024, 16:21 ET
- Period: 2024-04-10
- Accession: 0000950170-24-044424
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1652130/000095017024044424/ntla-20240410.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1652130/000095017024044424/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1652130/000095017024044424/ntla-20240410.htm

Filed Apr 15, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-044424. Last ingested by Listed: Nov 5, 2026, 17:50 ET. No prices; not investment advice.